Companion Diagnostics Market Size, Trends, and Growth Analysis 2026-2033 The Companion Diagnostics industry is witnessing robust growth driven by rapid advancements in personalized medicine and precision therapeutics. This market’s expansion underscores its critical role in enhancing targeted treatment efficacy, optimizing drug development, and improving patient outcomes across diverse healthcare sectors. Market Size and Overview Companion Diagnostics Market is estimated to be valued at USD 9.86 Bn in 2026 and is expected to reach USD 22.48 Bn in 2033, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033. #MolecularDiagnostics #CancerDiagnostics #OncologyDiagnostics #BiomarkerTesting #DiagnosticTesting

RNA Therapeutics Market Size, Trends, and Growth Analysis 2026-2033 The RNA therapeutics industry is witnessing unprecedented growth driven by breakthrough advancements in gene therapy and personalized medicine. Rapid innovations in RNA delivery systems, combined with expanding pipeline candidates, are fueling strong business growth in this dynamic sector. Market dynamics are shaped by evolving regulatory frameworks and increasing investments that underscore the market’s long-term potential. Market Size and Overview The RNA Therapeutics Market is estimated to be valued at USD 4.2 Mn in 2025 and is expected to reach USD 160.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 68.2% from 2025 to 2032. http://coherentmi.com/industry-reports/rna-therapeutics-market